SLC
LLY icon

Second Line Capital’s Eli Lilly LLY Stock Holding History

Second Line Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$540K Sell
450
-28
-6% -$28.6K 0.1% 79
2026
Q1 		$447K Hold
478
– – 0.08% 95
2025
Q4 		$514K Buy
+478
New +$457K 0.11% 75
2024
Q4 		– Sell
-227
Closed -$201K – 140
2024
Q3 		$201K Buy
+227
New +$204K 0.05% 130

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Second Line Capital's LLY Position: Q2 2026 in Review

Second Line Capital reduced its Eli Lilly (LLY) stake by 5.9% in Q2 2026, selling an estimated $28.6K and leaving 450 shares worth $540K. The position accounts for 0.1% of the portfolio, ranked #79.

Second Line Capital first reported a position in LLY in Q3 2024 and has held it in 4 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Second Line Capital held 450 shares of Eli Lilly worth $540K as of Q2 2026.
  • Second Line Capital sold 28 Eli Lilly shares in Q2 2026, an estimated $28.6K.
  • Eli Lilly made up 0.1% of Second Line Capital's portfolio in Q2 2026, its #79 holding.
  • Second Line Capital first reported a position in Eli Lilly in Q3 2024 and has held it in 4 quarters since.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Second Line Capital's 13F filing for Q2 2026, filed 12 Aug 2026.